| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.26M | 83.07M | 106.04M | 104.51M | 60.40M | 45.16M |
| Gross Profit | 13.69M | 14.40M | 18.73M | 21.09M | 12.24M | 7.33M |
| EBITDA | 1.17M | -323.37K | 6.58M | 8.27M | 3.93M | -1.89M |
| Net Income | -1.68M | -3.85M | 909.41K | 8.64M | 1.32M | -5.15M |
Balance Sheet | ||||||
| Total Assets | 48.86M | 58.17M | 68.37M | 78.50M | 43.80M | 26.29M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 0.00 | -1.94M | -7.48M | -1.78M |
| Total Debt | 18.84M | 17.70M | 31.00M | 39.59M | 23.89M | 12.63M |
| Total Liabilities | 29.31M | 38.56M | 45.83M | 56.09M | 32.08M | 15.73M |
| Stockholders Equity | 19.55M | 19.61M | 22.54M | 22.41M | 11.72M | 10.56M |
Cash Flow | ||||||
| Free Cash Flow | 4.59M | 9.97M | 12.00M | -10.67M | -9.26M | 10.22M |
| Operating Cash Flow | 5.04M | 10.39M | 12.69M | -8.57M | -9.22M | 10.22M |
| Investing Cash Flow | -453.25K | -414.09K | -676.64K | -2.10M | 40.11K | 1.43K |
| Financing Cash Flow | -4.59M | -9.97M | -12.01M | 10.67M | 9.18M | -10.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $1.34B | 11.09 | 18.06% | 3.57% | 9.24% | 6.35% | |
70 Outperform | C$221.98M | 9.69 | 11.94% | ― | -0.39% | -86.01% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | C$499.45M | 21.42 | 3.20% | ― | -8.13% | -28.00% | |
49 Neutral | C$6.48M | -3.85 | -8.25% | ― | -11.17% | 6.19% | |
49 Neutral | C$11.17M | -51.48 | -0.80% | ― | -75.46% | -100.66% |
Bri-Chem has launched a comprehensive strategic realignment under a newly reconstituted board, emphasizing internal manufacturing, product portfolio optimization, and tighter commercial discipline to strengthen its competitive position and financial resilience. The company is shifting select third-party products to in-house production, rationalizing underperforming SKUs, exiting the oil-based mud supply business, tightening customer return policies, closing underperforming facilities in Canada and the U.S. while retaining a presence in Houston, and consolidating real estate and workforce to cut SG&A by more than $1.6 million annually, all aimed at expanding margins, improving working capital, and positioning the business for more stable, diversified growth amid a steady to modestly improving industry backdrop in 2026.
The most recent analyst rating on (TSE:BRY) stock is a Hold with a C$0.20 price target. To see the full list of analyst forecasts on Bri-Chem stock, see the TSE:BRY Stock Forecast page.
Bri-Chem has announced the appointment of Mr. Barry Hugghins as the new CEO and President, who will also continue as Executive Chairman of the Board. In a move to align leadership with shareholder interests, Mr. Hugghins will receive a nominal salary of one dollar per year, while the Board of Directors will shift to equity-based compensation, reflecting a commitment to long-term shareholder value and enhanced governance.
Bri-Chem Corp. reported a 17% decrease in consolidated sales for Q3 2025, primarily due to reduced sales in its fluids distribution division and lower rig counts in North America. Despite the sales decline, the company saw improvements in adjusted EBITDA and operating earnings, attributed to a decrease in bad debt expenses. The company’s working capital decreased by 21%, reflecting a significant reduction in accounts receivables and inventory, although this was partially offset by decreased bank indebtedness. The decline in sales was influenced by the loss of a customer to a competitor, leading to service discontinuation, and a general downturn in rig activity in both Canada and the U.S.
Bri-Chem Corp. has announced the immediate departure of its CEO, Don Caron, as the company begins a leadership transition. The Board of Directors will manage interim responsibilities and search for a new CEO, ensuring no disruption to operations and maintaining focus on strategic priorities. The company remains committed to operational discipline and long-term growth, aiming to align performance across the organization and earn stakeholder confidence.